Nichtvirale sexuell übertragene Infektionen – Epidemiologie, Klinik, Labordiagnostik und Therapie

[1]  S. Pereyre,et al.  Fluoroquinolone-Resistant Mycoplasma genitalium, Southwestern France , 2016, Emerging infectious diseases.

[2]  W. I. van der Meijden,et al.  2016 European guideline on the management of non-gonococcal urethritis , 2016, International journal of STD & AIDS.

[3]  K. Workowski,et al.  Management of Gonorrhea in Adolescents and Adults in the United States. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  C. del Rio,et al.  Trends in Neisseria gonorrhoeae Susceptibility to Cephalosporins in the United States, 2006-2014. , 2015, JAMA.

[5]  P. Komericki,et al.  Die Gonokokkeninfektion in Österreich: Eine Langzeitbeobachtung der Prävalenz und Resistenzentwicklung von 1999 bis 2014 , 2015, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[6]  M. Unemo,et al.  Evaluation of the new AmpliSens multiplex real‐time PCR assay for simultaneous detection of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis , 2015, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[7]  Jason W. Lancaster,et al.  Update on Treatment Options for Gonococcal Infections , 2015, Pharmacotherapy.

[8]  Magnus Unemo,et al.  Current and future antimicrobial treatment of gonorrhoea – the rapidly evolving Neisseria gonorrhoeae continues to challenge , 2015, BMC Infectious Diseases.

[9]  M. Unemo,et al.  Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance , 2015, BMC Infectious Diseases.

[10]  K. Sardana,et al.  Rising trend of antimicrobial resistance among Neisseria gonorrhoeae isolates and the emergence of N. gonorrhoeae isolate with decreased susceptibility to ceftriaxone , 2015, Indian journal of medical microbiology.

[11]  J. Bazan,et al.  Disseminated gonococcal infection and eculizumab--a "high risk" connection? , 2014, Sexually transmitted diseases.

[12]  J. Papp,et al.  Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014. , 2014, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[13]  E. Hook,et al.  Vaginal swabs are the optimal specimen for detection of genital Chlamydia trachomatis or Neisseria gonorrhoeae using the Cobas 4800 CT/NG test. , 2013, Sexually transmitted diseases.

[14]  M. Unemo,et al.  Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. , 2012, Future microbiology.

[15]  D. Campos-Outcalt.  CDC update on gonorrhea: expand treatment to limit resistance. , 2011, The Journal of family practice.

[16]  M. Unemo,et al.  Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone , 2011, Antimicrobial Agents and Chemotherapy.

[17]  C. Gaydos,et al.  Performance of Three Nucleic Acid Amplification Tests for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by Use of Self-Collected Vaginal Swabs Obtained via an Internet-Based Screening Program , 2009, Journal of Clinical Microbiology.

[18]  Robert E. Johnson,et al.  Nucleic Acid Amplification Tests for Diagnosis of Neisseria gonorrhoeae Oropharyngeal Infections , 2009, Journal of Clinical Microbiology.